#NonStimulants

A major international analysis published in The Lancet Psychiatry finds that ADHD medications generally cause only minor cardiovascular effects, mainly small increases in heart rate and blood pressure. The study, led by researchers from the University of Southampton, reviewed data from 102 clinical trials involving more than 22,700 participants worldwide. It compared stimulant and non-stimulant ADHD treatments, concluding that while small heart-related changes occur, the overall benefits of these medicines often surpass the risks.

A comprehensive new analysis, published in The Lancet Psychiatry, underscores that medications prescribed for attention-deficit/hyperactivity disorder (ADHD) generally induce minor impacts on cardiovascular health, mostly characterized by slight elevations in heart rate and blood pressure. Conducted by an international team led by the University of Southampton, this large study evaluated data from 102 clinical trials involving over 22,702 participants globally, comparing both stimulant and non-stimulant medications used to treat ADHD. The news from this research provides a balanced view, suggesting that while there are small cardiovascular effects, the broader benefits of these medications often outweigh such risks.